Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

Share Price is delayed by 15 minutes
Get Live Data
44.50    0.00 (0.00%)
Bid:
44.00
Ask:
45.00
Spread: 1.00 (2.273%)
Market Cap: £85.38m
IOF Live PriceLast checked at - London Stock Exchange

Intraday Iofina Share Chart

Q3 2018 Update

10 Oct 2018 07:00

RNS Number : 4852D
Iofina PLC
10 October 2018
 
 

 

Iofina plc

("Iofina", the "Group", or the "Company")

(LSE AIM: IOF)

 

Q3 2018 Update

Record Quarterly Iodine Production Since Company Inception

 

Iofina, specialists in the exploration and production of iodine and halogen-based specialty chemical derivatives, today provides an update to the market regarding its activities during the third quarter ("Q3" or the "Period") of 2018.

 

During the Period, the Company produced the largest quarterly total of crystalline iodine in the history of the organisation, producing a total of 172.3 metric tonnes ("MT") of crystalline iodine from its four operating IOsorb® plants in Oklahoma. This was an increase of 37.8 per cent from the prior year (Q3 2017: 125 MT). This record production reflected a full quarter of strong performance at the new IO#7 plant, as well as continued consistent operation of our mature IOsorb® plants.

 

The Directors anticipate that this positive momentum will continue as the Company moves into the fourth quarter and the winter months. The Directors also remain confident that the Company will achieve the 2018 forecast total of 575-605 MT of crystalline iodine. Iofina's current total of 436.4 MT of produced crystalline iodine through September positions the Company well to significantly surpass 2017 totals (FY 2017: 503 MT). 

 

Commenting, President and CEO Dr. Tom Becker, stated: 

"I am proud of the record quarterly production that has been achieved in the history of Iofina, in the third quarter this year. The execution of the Company's growth strategy, in particular the advantageous location of IO#7, and the performance of the operations team, continues to pay off for the Company and its stakeholders.

 

"Iofina Chemical continues to trade well and is exploring additional revenue streams. Not only have we been marketing the Company's IOflo® crystalline iodine, but also its other chemical products.

 

"As recently stated in our interim results, announced on 20th September 2018, production and profitability continue to move in a positive direction. Debt restructure and growth in 2019 remain the top priority for myself and the management team as we move towards the end of 2018. We expect the positive momentum we are currently achieving to significantly increase the Group's revenues and profits versus the first half of this year."

 

Enquiries:

 

Iofina plc

Dr. Tom Becker, CEO & President

Tel: +44 (0)20 3006 3135

www.iofina.com

 

finnCap Ltd

Christopher Raggett/Anthony Adams/Camille Gochez

Tel: +44 (0)20 7220 0500

 

Media Contact:

Yellow Jersey

Charles Goodwin/Harriet Jackson

Tel: +44 (0)7544 275 882

 About Iofina:

Iofina specialises in the exploration and production of iodine, halogen based specialty chemical derivatives and produced water. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America, based on Iofina's WET® IOsorb® technology. Iofina has production operations in the United States, specifically in Kentucky and Oklahoma. It is a vertically integrated company, covering the process from the production of iodine in the field, to the manufacture of the chemical end-products derived from iodine, supplying them to the consumer, and the recycling of iodine using iodinated side-streams from waste chemical processes. Iofina utilises its portfolio of patented and patent-pending technology, and proprietary methods and trademarks throughout all business lines.

www.iofina.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDDKLFBVBFLFBV
Date   Source Headline
19th May 20204:36 pmRNSPrice Monitoring Extension
15th May 20204:40 pmRNSSecond Price Monitoring Extn
15th May 20204:35 pmRNSPrice Monitoring Extension
14th May 20207:00 amRNSPPP Loan Received
4th May 20207:00 amRNSIO#8 Brine Supply Update
14th Apr 20207:00 amRNSQ1 Market Update
2nd Apr 20207:00 amRNSDirectorate Change
26th Mar 20201:53 pmRNSWithdrawal of requisition for General Meeting
19th Mar 202012:08 pmRNSSecond Price Monitoring Extn
19th Mar 202012:03 pmRNSPrice Monitoring Extension
17th Mar 20204:41 pmRNSSecond Price Monitoring Extn
17th Mar 20204:35 pmRNSPrice Monitoring Extension
16th Mar 202012:07 pmRNSSecond Price Monitoring Extn
16th Mar 202012:02 pmRNSPrice Monitoring Extension
12th Mar 20204:41 pmRNSSecond Price Monitoring Extn
12th Mar 20204:36 pmRNSPrice Monitoring Extension
12th Mar 20201:56 pmRNSClarification Regarding Media Reports
11th Mar 202012:08 pmRNSSecond Price Monitoring Extn
11th Mar 202012:02 pmRNSPrice Monitoring Extension
10th Mar 20207:30 amRNSBoard response to recent GM request
10th Mar 20207:00 amRNSRequisition of General Meeting
3rd Mar 20207:10 amRNSStatement re: press and social media reports
2nd Mar 202012:22 pmRNSHolding(s) in Company
25th Feb 202012:00 pmRNSMarket Update
10th Feb 20205:15 pmRNSHolding(s) in Company
10th Feb 20205:15 pmRNSHolding(s) in Company
16th Jan 20207:00 amRNSMarket Update - Strong H2 2019
2nd Jan 202011:11 amRNSHolding(s) in Company
20th Dec 20197:00 amRNSTrading Update
14th Nov 20193:51 pmRNSHolding(s) in Company
14th Nov 20193:50 pmRNSHolding(s) in Company
12th Nov 20191:43 pmRNSHolding(s) in Company
6th Nov 20197:00 amRNSIofinaEX Hemp Seed Investment
14th Oct 20197:00 amRNSQ3 2019 Update
26th Sep 201910:00 amRNSHolding(s) in Company
25th Sep 20194:35 pmRNSPrice Monitoring Extension
23rd Sep 20197:00 amRNSInterim Results
18th Sep 20197:00 amRNSTerms for IO#8 Finalised - Construction Commences
29th Aug 20194:41 pmRNSSecond Price Monitoring Extn
29th Aug 20194:35 pmRNSPrice Monitoring Extension
13th Aug 20197:00 amRNSIncorporation of IofinaEX Global
29th Jul 20197:00 amRNSGrant of Share Options
24th Jul 20193:08 pmRNSHolding(s) in Company
16th Jul 20192:17 pmRNSHolding(s) in Company
12th Jul 20197:00 amRNSH1 2019 Update
17th Jun 20191:49 pmRNSHolding(s) in Company
17th Jun 201910:55 amRNSHolding(s) in Company
17th Jun 201910:53 amRNSHolding(s) in Company
13th Jun 201912:00 pmRNSResult of AGM and Open Offer
13th Jun 20197:00 amRNSIofinaEX Application Conditionally Approved

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.